Carlsmed, which provides custom equipment and AI-enabled software for personalized spine fusion surgery, announced terms for its IPO. The Carlsbad, CA-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. Insiders intend to purchase $31 million worth of shares in the offering (31% of the deal). At the midpoint of the proposed range, Carlsmed would command a fully diluted market value of $430 million. Carlsmed is focused on becoming the standard of care for spine fusion surgery.
Read the full article: Spine Surgery-Focused Medtech Carlsmed Sets Terms for $101M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/112130/Spine-surgery-focused-medtech-Carlsmed-sets-terms-for-$101-million-IPO